{"schema_version":"bookimed.page-context.v1","id":"doctor-jacob-schroder","url":"https://hub.bookimed.com/heart-surgery/doctor-jacob-schroder/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/doctor-jacob-schroder.json","index_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/index.json","full_dataset_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/content.json","content_revision":"source-driven-rankings-20261008","date_modified":"2026-10-08","language":"en","kind":"doctor-profile","title":"Jacob N. Schroder: heart transplantation and LVAD care","summary":"Jacob Schroder leads surgical advanced heart-failure care at Duke. His remit connects heart transplantation with durable LVADs, temporary ECMO and total artificial-heart care, addressing different degrees and durations of circulatory support.","research_credit":{"name":"Yevhenii Kozlov","role":"Co-Founder of Bookimed","url":"https://us-uk.bookimed.com/ceo/kozlov/","contribution":"Research personally prepared and reviewed","assistance":"AI tools assisted source research."},"editorial_scope":"Source-based patient information; an individual treatment plan requires clinical review.","research_method":"How this guide is researched and compared Research project led by Yevhenii Kozlov . We link clinical guidance, primary studies and named hospital or offer sources beside the relevant statements. Comparisons distinguish individual operators from programme results and preserve the study population, follow-up and limitations. Prices are dated examples with their stated scope. Research and editorial preparation are separate from clinical review; no named clinician has medically reviewed this edition. Bookimed provides care coordination. Partner and reference programmes are identified from their sources; paid ordering is not used in our published-cohort comparison. Read the editorial policy .","key_takeaways":[{"label":"A range of support options","text":"Duke lists transplantation, LVAD, ECMO and total artificial heart within his surgical remit.","sources":["SP06"]},{"label":"An additional donor pathway","text":"He led the multicentre trial evaluating selected donor hearts after circulatory death, reanimated and assessed with extracorporeal perfusion.","sources":["SP06","SP17"]},{"label":"Six-month trial result","text":"In 166 recipients in the primary as-treated analysis, adjusted six-month survival was 94% for the studied DCD pathway versus 90% for brain-death donation.","sources":["SP17"]}],"benefits":[{"text":"Transplantation and temporary or durable mechanical support are available within the same surgical remit, with trial evidence for an additional selected donor-heart pathway.","sources":["SP06","SP17"]}],"limitations":[{"text":"The trial met a noninferiority endpoint, not proof of superiority or lifelong equivalence. It studied selected donors, recipients and a specific perfusion system, and was funded by TransMedics.","sources":["SP06","SP17","SP05"]}],"sections":[{"id":"benefit-balance","title":"Benefits and limitations","text":"Benefits and limitations Potential advantages Transplantation and temporary or durable mechanical support are available within the same surgical remit, with trial evidence for an additional selected donor-heart pathway. Sources: Jacob N. Schroder named Surgical Director for Advanced Heart Failure · Transplantation Outcomes with Donor Hearts after Circulatory Death. Trade-offs and limits The trial met a noninferiority endpoint, not proof of superiority or lifelong equivalence. It studied selected donors, recipients and a specific perfusion system, and was funded by TransMedics. Sources: Jacob N. Schroder named Surgical Director for Advanced Heart Failure · Transplantation Outcomes with Donor Hearts after Circulatory Death. · Jacob Niall Schroder — faculty profile","links":[{"label":"Jacob N. Schroder named Surgical Director for Advanced Heart Failure","url":"https://surgery.duke.edu/news/jacob-n-schroder-md-named-surgical-director-advanced-heart-failure"},{"label":"Transplantation Outcomes with Donor Hearts after Circulatory Death.","url":"https://pubmed.ncbi.nlm.nih.gov/37285526/"},{"label":"Jacob N. Schroder named Surgical Director for Advanced Heart Failure","url":"https://surgery.duke.edu/news/jacob-n-schroder-md-named-surgical-director-advanced-heart-failure"},{"label":"Transplantation Outcomes with Donor Hearts after Circulatory Death.","url":"https://pubmed.ncbi.nlm.nih.gov/37285526/"},{"label":"Jacob Niall Schroder — faculty profile","url":"https://medschool.duke.edu/profile/jacob-niall-schroder"}]},{"id":"research","title":"Procedure-specific research","text":"Procedure-specific research DCD trial: what was established The 2023 multicentre randomized trial led by Schroder met its noninferiority endpoint for risk-adjusted survival six months after transplantation using the studied DCD/perfusion pathway. How to interpret this: Primary analysis was as treated. Selected donors, recipients and equipment limit generalization; this is not a personal survival rate, universal eligibility rule or long-term equivalence claim. Sources: Transplantation Outcomes with Donor Hearts after Circulatory Death.","links":[{"label":"Transplantation Outcomes with Donor Hearts after Circulatory Death.","url":"https://pubmed.ncbi.nlm.nih.gov/37285526/"}]},{"id":"team","title":"Clinical programme","text":"Clinical programme Duke University Hospital → Durham, North Carolina, United States Duke combines cardiac and vascular aortic expertise with an advanced heart-failure service. Hughes’s team covers the root through the thoraco-abdominal aorta; Schroder’s surgical remit includes transplantation, LVAD, ECMO and total artificial heart. Sources: Duke Center for Aortic Disease combines cardiothoracic and vascular surgery · G. Chad Hughes, MD · Mid-term outcomes of aortic valve repair using an anatomically shaped internal annuloplasty ring. · Jacob N. Schroder named Surgical Director for Advanced Heart Failure · Jacob Niall Schroder — faculty profile · Transplantation Outcomes with Donor Hearts after Circulatory Death. Explore the programme and other specialists →","links":[{"label":"Duke University Hospital →","url":"https://hub.bookimed.com/heart-surgery/clinic-duke/"},{"label":"Duke Center for Aortic Disease combines cardiothoracic and vascular surgery","url":"https://physicians.dukehealth.org/articles/duke-center-aortic-disease-combines-expertise-cardiothoracic-and-vascular-surgery"},{"label":"G. Chad Hughes, MD","url":"https://www.dukehealth.org/find-doctors-physicians/g-chad-hughes-md"},{"label":"Mid-term outcomes of aortic valve repair using an anatomically shaped internal annuloplasty ring.","url":"https://pubmed.ncbi.nlm.nih.gov/38006340/"},{"label":"Jacob N. Schroder named Surgical Director for Advanced Heart Failure","url":"https://surgery.duke.edu/news/jacob-n-schroder-md-named-surgical-director-advanced-heart-failure"},{"label":"Jacob Niall Schroder — faculty profile","url":"https://medschool.duke.edu/profile/jacob-niall-schroder"},{"label":"Transplantation Outcomes with Donor Hearts after Circulatory Death.","url":"https://pubmed.ncbi.nlm.nih.gov/37285526/"},{"label":"Explore the programme and other specialists →","url":"https://hub.bookimed.com/heart-surgery/clinic-duke/"}]}],"introduction":"Heart surgery guide / Jacob N. Schroder Jacob N. Schroder · Decision guide Jacob N. Schroder: heart transplantation and LVAD care Transplantation, LVAD and temporary support in one service · Durham, North Carolina, United States Research by Yevhenii Kozlov · Co-Founder of Bookimed Updated 8 October 2026 Sources linked throughout At a glance Jacob Schroder leads surgical advanced heart-failure care at Duke. His remit connects heart transplantation with durable LVADs, temporary ECMO and total artificial-heart care, addressing different degrees and durations of circulatory support. A range of support options Duke lists transplantation, LVAD, ECMO and total artificial heart within his surgical remit. Sources: Jacob N. Schroder named Surgical Director for Advanced Heart Failure An additional donor pathway He led the multicentre trial evaluating selected donor hearts after circulatory death, reanimated and assessed with extracorporeal perfusion. Sources: Jacob N. Schroder named Surgical Director for Advanced Heart Failure · Transplantation Outcomes with Donor Hearts after Circulatory Death. Six-month trial result In 166 recipients in the primary as-treated analysis, adjusted six-month survival was 94% for the studied DCD pathway versus 90% for brain-death donation. Sources: Transplantation Outcomes with Donor Hearts after Circulatory Death. Portrait source ↗ cardiac surgeon Jacob N. Schroder Duke University Hospital → Surgical Director for Advanced Heart Failure Surgical Director for Advanced Heart Failure · Durham, North Carolina, United States. Read the clinical or research source ↗","related_documents":[{"id":"heart-surgery","title":"Heart surgery abroad: treatments, clinics and costs","kind":"home","url":"https://hub.bookimed.com/heart-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/heart-surgery.json"},{"id":"surgeons","title":"Find cardiac surgeons and heart specialists by procedure","kind":"surgeons","url":"https://hub.bookimed.com/heart-surgery/surgeons/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/surgeons.json"},{"id":"heart-failure-surgery","title":"Heart failure surgery: underlying causes, LVAD and transplant","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/heart-failure-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/heart-failure-surgery.json"},{"id":"surgeon-rankings","title":"Heart surgeon rankings by reported experience, method and results","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/surgeon-rankings/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/surgeon-rankings.json"},{"id":"clinic-duke","title":"Duke University Hospital: heart surgery expertise","kind":"clinic-profile","url":"https://hub.bookimed.com/heart-surgery/clinic-duke/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/clinic-duke.json"}],"entity":{"id":"jacob-schroder","name":"Jacob N. Schroder","programme_id":"duke","role":"Surgical Director for Advanced Heart Failure","procedure_relevance":["Heart transplantation, LVAD and temporary mechanical support within advanced heart failure care."],"source_ids":["SP06","SP17","SP05"],"official_url":"https://medschool.duke.edu/profile/jacob-niall-schroder","clinical_role_type":"surgeon","topic_slugs":["heart-failure-surgery"],"method_tags":["heart-transplant","lvad","ecmo","advanced-heart-failure"],"profile":{"intro":"Jacob Schroder leads surgical advanced heart-failure care at Duke. His remit connects heart transplantation with durable LVADs, temporary ECMO and total artificial-heart care, addressing different degrees and durations of circulatory support.","clinical_focus":[{"label":"A range of support options","text":"Duke lists transplantation, LVAD, ECMO and total artificial heart within his surgical remit.","source_ids":["SP06"]},{"label":"An additional donor pathway","text":"He led the multicentre trial evaluating selected donor hearts after circulatory death, reanimated and assessed with extracorporeal perfusion.","source_ids":["SP06","SP17"]},{"label":"Six-month trial result","text":"In 166 recipients in the primary as-treated analysis, adjusted six-month survival was 94% for the studied DCD pathway versus 90% for brain-death donation.","source_ids":["SP17"]}],"evidence":[{"title":"DCD trial: what was established","summary":"The 2023 multicentre randomized trial led by Schroder met its noninferiority endpoint for risk-adjusted survival six months after transplantation using the studied DCD/perfusion pathway.","source_ids":["SP17"],"limitations":"Primary analysis was as treated. Selected donors, recipients and equipment limit generalization; this is not a personal survival rate, universal eligibility rule or long-term equivalence claim."}],"consultation_questions":[],"current_role_note":"Surgical Director for Advanced Heart Failure · Durham, North Carolina, United States.","key_takeaways":[{"label":"A range of support options","text":"Duke lists transplantation, LVAD, ECMO and total artificial heart within his surgical remit.","sources":["SP06"]},{"label":"An additional donor pathway","text":"He led the multicentre trial evaluating selected donor hearts after circulatory death, reanimated and assessed with extracorporeal perfusion.","sources":["SP06","SP17"]},{"label":"Six-month trial result","text":"In 166 recipients in the primary as-treated analysis, adjusted six-month survival was 94% for the studied DCD pathway versus 90% for brain-death donation.","sources":["SP17"]}],"benefits":[{"text":"Transplantation and temporary or durable mechanical support are available within the same surgical remit, with trial evidence for an additional selected donor-heart pathway.","sources":["SP06","SP17"]}],"limitations":[{"text":"The trial met a noninferiority endpoint, not proof of superiority or lifelong equivalence. It studied selected donors, recipients and a specific perfusion system, and was funded by TransMedics.","sources":["SP06","SP17","SP05"]}],"patient_sections":[{"id":"benefit-balance","title":"Benefits and limitations","paragraphs":[],"items":[],"sources":[],"kind":"benefit-balance","links":[],"table":null},{"id":"research","title":"Procedure-specific research","paragraphs":[],"items":[],"sources":[],"kind":"doctor-evidence","links":[],"table":null},{"id":"team","title":"Clinical programme","paragraphs":[],"items":[],"sources":[],"kind":"doctor-clinic","links":[],"table":null}]},"bookimed_route":null,"portrait":{"url":"https://hub.bookimed.com/wp-content/uploads/2026/10/jacob-schroder-200x300.jpg","source_page":"https://medschool.duke.edu/profile/jacob-niall-schroder","width":1200,"height":1800,"alt":"Jacob Niall Schroder"},"topics":["hf"],"headline":"heart transplantation and LVAD care","profile_slug":"doctor-jacob-schroder","discipline":"cardiac surgeon"},"sources":{"pd-adult-hughes-official":{"title":"G. Chad Hughes, MD","publisher":"Duke Health","url":"https://www.dukehealth.org/find-doctors-physicians/g-chad-hughes-md","read_at":"2026-10-08","kind":"official provider or programme page","support":"Active adult heart surgeon; valve repair, valve-sparing root, arch, thoracoabdominal, TEVAR and TAVR expertise.","limitations":"An institutional listing supports current role and stated clinical scope; it does not establish the next appointment, operating allocation or individual risk-adjusted results.","body_file":"outputs/heart-surgery-hub-20261007/review/provider-depth/adult/sources/hughes-official.txt"},"pd-adult-duke-programme":{"title":"Duke Center for Aortic Disease combines cardiothoracic and vascular surgery","publisher":"Duke Health","url":"https://physicians.dukehealth.org/articles/duke-center-aortic-disease-combines-expertise-cardiothoracic-and-vascular-surgery","read_at":"2026-10-08","kind":"official provider or programme page","support":"Hughes is co-director and aortic surgery section chief; coordinated imaging/genetics/lifelong follow-up.","limitations":"An institutional listing supports current role and stated clinical scope; it does not establish the next appointment, operating allocation or individual risk-adjusted results.","body_file":"outputs/heart-surgery-hub-20261007/review/provider-depth/adult/sources/web-body-observations.md","published_at":"2025-08-05"},"pd-adult-hughes71":{"title":"Mid-term outcomes of aortic valve repair using an anatomically shaped internal annuloplasty ring.","publisher":"European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/38006340/","read_at":"2026-10-08","kind":"original study abstract and author/affiliation record","support":"Abstract body and authorship inspected; numerical claims below are restricted to the reported endpoint and population.","limitations":"Full manuscript and supplementary operator allocations were not read in this pass. Authorship is not an individual surgical outcome series.","body_file":"outputs/heart-surgery-hub-20261007/review/provider-depth/adult/sources/hughes71.json","published_at":"2023-12-01","doi":"10.1093/ejcts/ezad395","authors":"Jarral OA, Jensen CW, Doberne JW, Downey PS, Serfas JD, Vekstein AM, Hughes GC."},"SP05":{"title":"Jacob Niall Schroder — faculty profile","publisher":"Duke University School of Medicine","url":"https://medschool.duke.edu/profile/jacob-niall-schroder","read_at":"2026-10-08","source_kind":"official-institution","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/schroder-current.txt","supports":"Current Surgical Director for Advanced Heart Failure and faculty role.","limitations":""},"SP06":{"title":"Jacob N. Schroder named Surgical Director for Advanced Heart Failure","publisher":"Duke Department of Surgery","url":"https://surgery.duke.edu/news/jacob-n-schroder-md-named-surgical-director-advanced-heart-failure","read_at":"2026-10-08","source_kind":"official-institution","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/schroder-role.txt","supports":"Remit includes heart transplantation, LVAD, ECMO, total artificial heart and conventional cardiac surgery with severely reduced LV function; direct DCD transplant operator history.","limitations":"Appointment story dated 2024; title cross-checked against live SP05. Historical volumes are not current annual performance.","published_at":"2024-01-22"},"SP17":{"title":"Transplantation Outcomes with Donor Hearts after Circulatory Death.","publisher":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37285526/","read_at":"2026-10-08","published_at":"2023-06-01","doi":"10.1056/nejmoa2212438","pmid":"37285526","source_kind":"primary-research-abstract","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/pmid-37285526.json","supports":"Multicentre randomized noninferiority DCD donor-heart trial led by Schroder; risk-adjusted six-month survival met noninferiority endpoint.","limitations":"As-treated primary analysis, selected donors/recipients and specific ex-situ perfusion pathway; not all DCD pathways, all candidates or long-term equivalence. Funded by TransMedics."}}}